An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...
The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...
With the RSV season officially underway in South Africa, experts are urging healthcare providers to prepare for an influx of ...
Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...
Early data suggests that the respiratory syncytial virus (RSV) vaccination programme is significantly reducing hospital admissions among ...
Starting this spring, the Respiratory Syncytial Virus (RSV) vaccine will be available to adults aged 60 years and older residing in congregate living facilities, such as long-term care homes and ...
In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...
A review and meta-analysis finds mass biannual azithromycin distribution reduced mortality by 15% in children ages 1 to 5 in ...